Skip to content

Clinical trials

Phase 3 Lymphoma, Large B-Cell, Diffuse trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 3 Country / region: Taiwan Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20112
20121
20132
20151
20171
20191
20202
20213
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting8
Completed6
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
Genmab3
Janssen Research & Development, LLC2
Acerta Pharma BV1
Arbeitsgemeinschaft medikamentoese Tumortherapie1
Celgene1
Incyte Corporation1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse18
Lymphoma, Non-Hodgkin5
Lymphoma3
Lymphoma, B-Cell3
Neoplasms2
Bronchiolitis Obliterans Syndrome1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphatic Diseases1
Lymphoma, Follicular1
Lymphoma, Mantle-Cell1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.